2025-07-28 – Press Releases – www.prnewswire.com
– This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks the third approved indication of the drug in China. – XPOVIO® as a monotherapy in patients…
